BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11882362)

  • 1. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
    Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
    Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
    Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of human umbilical cord blood-derived T-lymphocytes with homologous cord blood plasma.
    Kim YM; Jung MH; Song HY; Yang HO; Lee ST; Kim JH; Kim YT; Nam JH; Mok JE
    Tohoku J Exp Med; 2005 Feb; 205(2):115-22. PubMed ID: 15673969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation.
    Davis CC; Marti LC; Sempowski GD; Jeyaraj DA; Szabolcs P
    Cancer Res; 2010 Jul; 70(13):5249-58. PubMed ID: 20530666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation.
    Mazur MA; Davis CC; Szabolcs P
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1190-1196. PubMed ID: 18804050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-15 on anti-CD3/anti-CD28 induced apoptosis of umbilical cord blood CD4+ T cells.
    Lin SJ; Yu JC; Cheng PJ; Hsiao SS; Kuo ML
    Eur J Haematol; 2003 Dec; 71(6):425-32. PubMed ID: 14703692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.
    Carlens S; Gilljam M; Remberger M; Aschan J; Christensson B; Dilber MS
    Exp Hematol; 2000 Oct; 28(10):1137-46. PubMed ID: 11027832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
    Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
    Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood T cells cultured with IL-7 in addition to IL-2 exhibit a higher degree of polyfunctionality and superior proliferation potential.
    Berglund S; Gertow J; Magalhaes I; Mattsson J; Uhlin M
    J Immunother; 2013 Oct; 36(8):432-41. PubMed ID: 23994891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
    Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
    Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evaluation of ex vivo expanded cord blood lymphocytes: possible use for adoptive cellular immunotherapy.
    Azuma H; Yamada Y; Shibuya-Fujiwara N; Yamaguchi M; Murahashi H; Fujihara M; Sato N; Fukazawa K; Ikebuchi K; Ikeda H
    Exp Hematol; 2002 Apr; 30(4):346-51. PubMed ID: 11937270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2006 Nov; 67(11):874-83. PubMed ID: 17145367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
    Lee CC; Lin SJ; Cheng PJ; Kuo ML
    Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
    St John LS; Wan L; He H; Garber HR; Clise-Dwyer K; Alatrash G; Rezvani K; Shpall EJ; Bollard CM; Ma Q; Molldrem JJ
    Cytotherapy; 2016 Aug; 18(8):995-1001. PubMed ID: 27378343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.